相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific
Julius Benicky et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
Giuliano Tocci et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays
Kim Brint Pedersen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension
Srinivas Sriramula et al.
CARDIOVASCULAR RESEARCH (2011)
Biliverdin protects against the deterioration of glucose tolerance in db/db mice
N. Ikeda et al.
DIABETOLOGIA (2011)
ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function
Huijing Xia et al.
PLOS ONE (2011)
Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)
Sergio Henrique S. Santos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension
Yumei Feng et al.
CIRCULATION RESEARCH (2010)
Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets
Benedikt Treml et al.
CRITICAL CARE MEDICINE (2010)
Angiotensin I-Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice
Sharell M. Bindom et al.
DIABETES (2010)
Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats
Jorge F. Giani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycentic Control
Masanori Mitsuishi et al.
DIABETES (2009)
Crosstalk between insulin and angiotensin II signalling systems
F. Folli et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Angiotensin II Type 1 Receptor-Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice
Huijing Xia et al.
HYPERTENSION (2009)
The sweeter side of ACE2: Physiological evidence for a role in diabetes
Sharell M. Bindom et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus
Atsuhito Salki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Decreased Expression of Angiotensin-Converting Enzyme 2 in Pancreatic Ductal Adenocarcinoma Is Associated with Tumor Progression
Lin Zhou et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression
J-C Zhong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation
Yumei Feng et al.
CIRCULATION RESEARCH (2008)
Genetically altered animal models for Mas and angiotensin-(1-7)
Natalia Alenina et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
Heather N. Reich et al.
KIDNEY INTERNATIONAL (2008)
Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice
Ming-Jia Niu et al.
ENDOCRINE (2008)
Association of oxidative stress, insulin resistance, and diabetes risk phenotypes - The framingham offspring study
James B. Meigs et al.
DIABETES CARE (2007)
ACE2: A new target for cardiovascular disease therapeutics
Mohan K. Raizada et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Peroxisome proliferator-activated receptor α/γ dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice
Dae Ryong Cha et al.
DIABETES (2007)
Improvement of insulin sensitivity by antagonism of the renin-angiotensin system
Erik J. Henriksen
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats
Zhen Huang et al.
CLINICAL SCIENCE (2007)
Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: Implications for albuminuria in diabetes
Minghao Ye et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes
KY Chu et al.
DIABETES (2006)
Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat
C Tikellis et al.
DIABETES (2004)
Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes
RP Robertson
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice
T Shiuchi et al.
HYPERTENSION (2004)
Sarcosine1,glycine8 angiotensin II is an AT1 angiotensin II receptor subtype selective antagonist
RC Speth
REGULATORY PEPTIDES (2003)
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy
C Tikellis et al.
HYPERTENSION (2003)
Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool
GM Butz et al.
PHYSIOLOGICAL GENOMICS (2001)
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
M Donoghue et al.
CIRCULATION RESEARCH (2000)
分享论文
